Appleton Partners Inc Bristol Myers Squibb CO Transaction History

Appleton Partners Inc

$1.36 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 02, 2024	SELL	$48.48 - $57.85 $30,009 - $35,809	-619 Reduced 8.87%	6,358 $326,000
Q3 2023 Oct 03, 2023	SELL	$57.89 - $64.73 $32,128 - $35,925	-555 Reduced 7.37%	6,977 $405,000
Q2 2023 Jul 10, 2023	SELL	$63.71 - $70.74 $83,014 - $92,174	-1,303 Reduced 14.75%	7,532 $482,000
Q1 2023 Apr 10, 2023	BUY	$65.71 - $74.53 $15,836 - $17,961	241 Added 2.8%	8,835 $612,000
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $48,620 - $57,573	-710 Reduced 7.63%	8,594 $618,000
Q3 2022 Oct 27, 2022	SELL	$0.13 - $76.84 $71 - $42,185	-549 Reduced 5.57%	9,304 $661,000
Q2 2022 Jul 08, 2022	BUY	$72.62 - $79.98 $26,215 - $28,872	361 Added 3.8%	9,853 $759,000
Q1 2022 Apr 05, 2022	SELL	$61.48 - $73.72 $16,292 - $19,535	-265 Reduced 2.72%	9,492 $693,000
Q4 2021 Feb 03, 2022	SELL	$53.63 - $62.52 $156,975 - $182,996	-2,927 Reduced 23.08%	9,757 $608,000
Q3 2021 Oct 14, 2021	BUY	$59.17 - $69.31 $52,779 - $61,824	892 Added 7.56%	12,684 $751,000
Q2 2021 Jul 07, 2021	SELL	$61.91 - $67.42 $44,575 - $48,542	-720 Reduced 5.75%	11,792 $788,000
Q1 2021 Apr 19, 2021	SELL	$59.34 - $66.74 $24,804 - $27,897	-418 Reduced 3.23%	12,512 $790,000
Q3 2020 Oct 14, 2020	SELL	$57.43 - $63.64 $12,806 - $14,191	-223 Reduced 1.7%	12,930 $780,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $54 - $64	-1 Reduced 0.01%	13,153 $773,000
Q1 2020 May 04, 2020	SELL	$46.4 - $67.43 $67,976 - $98,784	-1,465 Reduced 10.02%	13,154 $733,000
Q4 2019 Jan 13, 2020	BUY	$49.21 - $64.19 $184,291 - $240,391	3,745 Added 34.44%	14,619 $938,000
Q3 2019 Nov 04, 2019	SELL	$42.77 - $50.71 $13,130 - $15,567	-307 Reduced 2.75%	10,874 $551,000
Q2 2019 Jul 25, 2019	SELL	$44.62 - $49.34 $94,148 - $104,107	-2,110 Reduced 15.88%	11,181 $507,000
Q1 2019 Apr 17, 2019	BUY	$45.12 - $53.8 $24,184 - $28,836	536 Added 4.2%	13,291 $634,000
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $185,824 - $240,969	-3,811 Reduced 23.0%	12,755 $663,000
Q3 2018 Oct 09, 2018	SELL	$55.19 - $62.25 $72,740 - $82,045	-1,318 Reduced 7.37%	16,566 $1.03 Million
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $76,805 - $95,729	-1,520 Reduced 7.83%	17,884 $990,000
Q1 2018 Apr 11, 2018	SELL	$59.92 - $68.98 $19,893 - $22,901	-332 Reduced 1.68%	19,404 $1.23 Million
Q4 2017 Jan 12, 2018	SELL	$59.94 - $65.35 $82,477 - $89,921	-1,376 Reduced 6.52%	19,736 $1.21 Million
Q3 2017 Oct 12, 2017	BUY	$55.23 - $63.74 $1.17 Million - $1.35 Million	21,112	21,112 $1.35 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Partners Inc with notifications on news.

Account